EmaxHealth

Health knowledge and news provided by doctors.

Ads by Google

Arthritis Pain Treatment

Whether you have osteoarthritis, rheumatoid arthritis, or one of the approximately 100 other forms of this disease, Emaxhealth reporters provide the latest research coverage. You also can turn to these pages for useful lifestyle suggestions and other information that can help you better manage and live with arthritis.

Golimumab Effective In Patients With Active Rheumatoid Arthritis

Patients with moderately-to-severely active rheumatoid arthritis who were previously treated with anti-tumor necrosis factor-alpha agents, experienced significant improvements in signs and symptoms and physical function after receiving every four-week subcutaneous injections of golimumab.

Staying Active Best Way To Control Arthritis Pain

Arthritis affects one in every four adults in Wisconsin, and nationally it is the most common cause of disability. Yet state health officials report that if arthritis sufferers exercise for short periods of time, despite their discomfort, they can come one step closer to relieving some of their aches and pains.

Trubion Initiates Study Of TRU-015 For Rheumatoid Arthritis Treatment

Wyeth Pharmaceuticals has commenced patient dosing in the next Phase 2b clinical trial of TRU-015 in patients with rheumatoid arthritis (RA). In collaboration with Trubion, Wyeth Pharmaceuticals is developing TRU-015, SBI-087 and other CD20-directed products.

Trubion Initiates Study Of SBI-087 For Rheumatoid Arthritis Treatment

Wyeth Pharmaceuticals has initiated a Phase 1 clinical trial of SBI-087, a next-generation drug candidate for the treatment of rheumatoid arthritis (RA). In collaboration with Trubion, Wyeth Pharmaceuticals is developing SBI-087 and other CD20-directed products. SBI-087 for RA builds on Trubion and Wyeth's clinical experience with Trubion's lead compound, TRU-015, and is based on Trubion's Small Modular ImmunoPharmaceutical (SMIP) technology.

Pine Bark Naturally Reduces Osteoarthritis

More than 20 million Americans suffer from osteoarthritis, with half a million Americans having a total joint replacement each year. A new study to be published in the April 2008 edition (Volume 22, issue No 4) of the journal of Phytotherapy Research shows Pycnogenol (pic-noj-en-all), an antioxidant plant extract from the bark of the French maritime pine tree, was shown to reduce all osteoarthritis symptoms by 56 percent. The study revealed a particularly high efficacy of Pycnogenol for lowering joint pain by 55 percent.

Pages